NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Whole blood cryopreservation in epidemiological studies.

Author(s): Hayes RB, Smith CO, Huang WY, Read Y, Kopp WC

Publication: Cancer Epidemiol Biomarkers Prev, 2002, Vol. 11, Page 1496-8

PubMed ID: 12433734 PubMed Review Paper? No

Suggested by: ISBER


Purpose of Paper

The purpose of this paper was to determine the effects of whole blood storage on lymphocyte viability, T-cell proliferation, and Epstein-Barr virus (EBV) transformation of B-cells.

Conclusion of Paper

Lymphocyte viability was decreased after whole blood was frozen and stored for one day, but increasing amounts of storage time had no additional effect. The percentage of T-cells, and T-cell:B-cell ratios were unaffected by storage of whole blood for one day, but each increased with increasing storage duration. Further, T-cell proliferation decreased with longer storage. EBV-transformation was unaffected by frozen storage of whole blood for up to 20 months.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of storage of whole blood on lymphocyte viability, T-cell proliferation, and EBV-transformation of B-cells.

    Summary of Findings:

    An average of 98.4% of lymphocytes separated from fresh whole blood were viable, but after whole blood was frozen and stored for one day, that average decreased to 85.2%. Additional frozen storage up to 31 months did not significantly decrease lymphocyte viability. Freezing whole blood specimens for 1 day did not affect the percentage of T-cells or T-cell:B-cell ratios, however, both increased significantly with longer storage. T-cell proliferation decreased with longer storage. After 2 attempts, 92.5% of specimens stored for up to 20 months were successfully transformed with EBV taking an average time of 38.2 days.

    Biospecimens
    Preservative Types
    • Frozen
    • None (Fresh)
    Diagnoses:
    • Not specified
    Platform:
    AnalyteTechnology Platform
    Cell count/volume Flow cytometry
    Cell count/volume Macroscopic observation
    Cell count/volume Radioassay
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Anticoagulant Acid-citrate-dextrose
    Storage Storage temperature -150 degrees C
    Storage Storage duration 0 d
    1 d
    1 month
    7 months
    18 months
    20 months
    31 months
    Biospecimen Preservation Type of fixation/preservation Frozen
    None (fresh)
    Biospecimen Aliquots and Components Blood and blood products Lymphocyte

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...